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Background: We investigated whether low socioeconomic status (SES), which is
associated with reduced health and life expectancy, might play a role in increased
risk for infectious diseases. Therefore, we explored the association between SES and
immunoglobulin G (IgG) levels against various pathogens.
Methods: We analyzed the association between SES [educational level and
net household income (NHI)] and serum IgG concentration against measles,
mumps, rubella, varicella, Haemophilus influenzae type B (HiB), pneumococcus,
meningococcus serogroup C (MenC), and cytomegalovirus (CMV) collected within a
national cross-sectional serosurvey (2006/2007) using linear regression analyses among
non-vaccinated individuals.
Results: Higher educational level was associated with higher IgG concentrations against
measles (GMC ratio 1.34, 95% CI 1.18–1.53) and rubella (1.13, 1.02–1.25) compared
to low education level. In contrast, higher education level was associated with lower IgG
concentrations against pneumococcus (0.78, 0.70–0.88), MenC (0.54, 0.44–0.68), and
CMV (0.23, 0.18–0.31) compared to low education level. This pattern was also evident
when NHI was used as SES indicator.
Conclusion: Our study suggests that socioeconomic status is associated with
antibody levels in a pathogen-dependent manner. The results suggest that differences in
serological response upon infection or differences in exposure might be involved in the
variation in IgG levels between SES groups.
Keywords: vaccine preventable diseases, immunoglobulin G, socioeconomic status, antibody level,
cytomegalovirus
INTRODUCTION
Socioeconomic status (SES) is a well-known determinant for health status and lower life
expectancy. SES is often determined by income or educational level and forms an important factor
in health studies (1, 2). While a lot of research focused on the relation between SES and chronic
diseases, only few studies have investigated the association of SES with infectious diseases. Several
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studies have shown that individuals with a lower SES have a
higher risk of being cytomegalovirus (CMV) seropositive (3–
5), a prevalent betaherpesvirus which has been suggested to
be associated with enhanced aging of the immune system.
This finding was also confirmed by a modeling study on SES
in relation to infection control, which showed a decreasing
CMV antibody response with increasing SES (6). A recent
study by Aiello et al. indeed suggests enhanced aging of the
immune system in individuals with low SES (7). Immune
responses play an important role in the outcome of infections
and differ between individuals. Diversity in immune responses
between individuals is attributable to genetics, age, sex, and the
environment (8). Perhaps SES is such an environmental influence
affecting immunity, and thereby may influence exposure to and
infection with pathogens. In addition, exposure to environmental
risk factors such as air pollution and crowding is thought to be
enhanced in individuals with low SES compared to high SES (9).
Whether the characteristics of low SES individuals as described
above contribute to altered immunity to encountered pathogens
as measured by immunoglobulin G (IgG), and whether this may
reflect their vulnerable health status, is unknown.
Since little is known about the association between SES
and naturally derived antibody levels against pathogens, this
study aimed to explore the association between SES and IgG
levels against multiple (vaccine preventable) infectious disease
causing agents. Presence of antibodies can be considered
indicative for exposure to or infection with the pathogen. To
provide an overview and to examine differences between
pathogens, IgG levels against measles, mumps, rubella,
varicella zoster virus (VZV), Haemophilus influenzae type
B (HiB), Streptococcus pneumoniae (pneumococcus), Neisseria
meningitidis (meningococcus) serogroup C (MenC), and CMV
were studied using data from a national serosurvey conducted
in the Netherlands in 2006-2007 (Pienter2 study). Vaccinations
against all these respiratory transmitted pathogens were included
in the National Immunization Program (NIP) of the Netherlands
during Pienter2, except for varicella and CMV (10). As we
wanted to study merely the effect of SES on natural infection,
we only included participants aged 40–79 years during the
serosurvey, as they were not yet immunized through the NIP
and the studied IgG levels are thus reflecting immunity acquired
through natural exposure to the pathogen.
MATERIALS AND METHODS
Study Design
The Pienter2 study (P2) is a Dutch population-wide cross-
sectional serosurvey conducted between February 2006 and June
2007, aiming to collect data at a national level on antibody
levels against pathogens that are targeted in the NIP. An
extensive study description can be found elsewhere (11, 12).
In short, the Netherlands were divided in five regions from
which 40 municipalities (eight from each region) were randomly
chosen, taken into account the number of inhabitants, to
participate in the study. During the study, 19781 participants
0–79 years of age were invited to fill in a questionnaire
and to donate a blood sample. This resulted in 6,348 (32%)
completed questionnaires with a supplementary blood sample in
the national sample including an oversampling of non-Western
migrants. The P2 project was approved by the medical ethics
testing committee of the foundation of therapeutic evaluation
of medicines (METC-STEG) in Almere (clinical trial number;
ISRCTN 20164309). Every participant signed an informed
consent prior to study participation. All participants from the
national sample (including oversampled migrants) who were 40–
79 years of age were included in the current analyses (n= 2,743).
Laboratory Methods
Serological testing for antibodies against the different pathogens
was performed with a fluorescent bead-based multiplex
immunoassay (MMRV-MIA) using Luminex technology for
simultaneous detection of measles, mumps, rubella, and varicella
antibodies (13). For HiB, pneumococcus, and MenC antibody
concentrations were determined likewise in separate assays
(14, 15). Thirteen pneumococcal serotypes were analyzed in
this study (i.e., serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A,
19F, and 23F). For CMV an ELISA kit, ETI-CYTOK-G PLUS
(DiaSorin, Saluggia, Italy), was used with an upper detection limit
of 10 IU/mL (3). Measurements above this threshold were set at
10 IU/mL (n = 149). IgG concentrations against all pathogens
were determined and calibrated against internationally generally
accepted standards, such as the World Health Organization
(WHO) cut-offs.
Variables
For the measurement of socioeconomic status, the highest
completed level of education and the net household income per
month (NHI) were used as SES indicators. Educational level was
divided in the categories low (i.e., no or primary education),
intermediate (i.e., junior technical school, lower general or
intermediate vocational secondary education), and high (i.e.,
higher vocational or higher general secondary education, pre-
university or university education) (12). For NHI, low SES was
defined as <e1,150, intermediate SES as e1,151–e3,050, and
high SES as >e3,050 per month. As educational level and NHI
are related but are not considered to be interchangeable, we
decided to use both in separate analyses and in a combined
analysis (16). Other characteristics that might be related to SES
include age, sex, and ethnicity (16, 17). Therefore, the analyses
were conducted with all ages combined and stratified by age
group (i.e., 40–49, 50–59, 60–69, and 70–79 years). We also
performed unadjusted and adjusted analyses, taking into account
age category, sex, and ethnicity (Dutch vs. non-Dutch).
Data Analyses
We only included participants for whom all determinants and all
antibody response data were available, and who were most likely
not vaccinated against the selected pathogens (based on available
vaccination data). Geometric mean concentrations (GMC) with
95% confidence intervals (CI) were calculated per subgroup
based on the categorization of educational level or NHI, and
age. The survey design with five strata (regions) and 40 clusters
(municipalities) was taken into account in all analyses, which
corrected the standard error of the estimates.
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Linear regression analyses were performed to study the
association between SES and the logarithmically transformed
antibody concentration against the different pathogens. Separate
linear regression analyses were conducted between NHI and
educational level and pathogen-specific antibody level, for all
ages combined and stratified by age groups. In the crude model,
only the SES variable was included, while the adjusted model
included age category, sex, and ethnicity. The interaction with
age category was tested as well. We also performed a similar
analysis of educational level and NHI combined, in which we
only compared participants who were in the high category for
both educational level and NHI to participants who were in the
low category for educational level and NHI. The same was done
for people who were in the intermediate category for educational
level and NHI (vs. low category). In all analyses, we present the
results as GMC ratios comparing high and intermediate SES to
low SES.
In addition to the separate pneumococcal serotype specific
regression models, a generalized estimation equation model
(GEE) was applied to obtain an overall estimate of the GMC ratio
across all pneumococcal serotypes with corresponding 95% CI,
as the strength of the association with SES did not differ greatly
between serotypes. Themodel included the SES determinant, and
serotype for the crude estimates, combined with age category,
sex, and ethnicity for the adjusted estimates. An exchangeable
working correlation structure was used. P< 0.05 were considered
significant. All analyses were conducted in SAS 9.4.
Validation of Study Results
To validate our results, we performed the same analyses
using data from the Pienter1 study (P1), conducted between
October 1995 and December 1996, which has a study design
similar to P2 [details are described elsewhere (18)]. 15,189
inhabitants were invited to participate, of whom 8,539 (56%)
completed the questionnaire and donated a blood sample. For
the validation analyses in this project, 3,609 participants aged
40–79 years with questionnaires and blood samples available
were included in the analyses, without oversampling of Non-
Western migrants. In P1, only educational level as SES indicator
was available. Antibody concentrations against HiB, MenC,
and pneumococcus were determined in a similar manner
in P1 and P2 (15, 19). For measles, mumps, rubella, and
varicella antibodies were determined with ELISAs instead of
MIAs (20–23), which showed good correlation between the
assays (13). IgG levels against CMV were not determined.
IgG levels were not available for all participants, leaving 629
(varicella) to 3,575 samples (measles, mumps, rubella) available
for analysis (number of samples analyzed per pathogen are listed
in Figure 4).
RESULTS
General characteristics of participants from P2 who had
blood and questionnaires available are listed in Table 1
(n = 2,743). The majority of the study population was
Dutch (>80%). Seventy-one participants were excluded because
they received (part of a) MMR vaccination, 510 participants
TABLE 1 | Descriptive characteristics of participants from the Pienter2 national
sample 40–79 years, with blood sample and questionnaire available (N = 2,743).
Characteristic N (%)
SEX
Male 1,248 (45.5)
Female 1,495 (54.5)
AGE (YEARS)
40–49 641 (23.4)
50–59 713 (26.0)
60–69 797 (29.0)
70–79 592 (21.6)
EDUCATIONAL LEVELa
Low 373 (13.6)
Intermediate 1,442 (52.6)
High 887 (32.3)
Missing 41 (1.5)
NET HOUSEHOLD INCOME
Low (<e 1,150,-) 423 (15.4)
Intermediate (e1,151,- to e3,050,-) 1,368 (49.9)
High (>e3,050,-) 442 (16.1)
Missing 510 (18.6)
ETHNICITY
Dutch 2,228 (81.2)
Non-Dutch 515 (18.8)
URBANIZATION RATE
Very high (>2,500 addresses per km2) 565 (20.6)
High (1,500–2,500 addresses per km2 ) 1,238 (45.1)
Moderately high (1,000–1,500 addresses per km2) 353 (12.9)
Low (500–1,000 addresses per km2) 272 (9.9)
Very low (<500 addresses per km2 ) 315 (11.5)
NUMBER OF PEOPLE IN HOUSEHOLD
1–2 persons 1,840 (67.1)
≥3 persons 863 (31.5)
Missing 40 (1.4)
CHILD ≤4 YEAR IN HOUSEHOLD
Yes 69 (2.5)
No 2,674 (97.5)
PROFESSION WITH CHILDREN
Yes 381 (13.9)
No 2,361 (86.1)
ANY MMR VACCINATION RECEIVED (WHOLE OR PART)
Yes 71 (2.6)
No 2,672 (97.4)
aLow educational level was defined as no education or primary education, intermediate
educational level was defined as junior technical school, lower general or intermediate
vocational secondary education, and high educational level was defined as higher
vocational or higher general secondary education, pre-university or university education
(according to CBS).
were excluded as no information on NHI was available,
and 41 participants were excluded, as educational level was
unknown. This left us with 2,172 participants for the NHI
analyses, and 2,627 participants for the educational level
analyses.
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FIGURE 1 | Crude geometric mean concentration ratios per pathogen of high and intermediate educational level vs. low educational level with corresponding 95%
C.I. N = 2,627.
FIGURE 2 | Crude geometric mean concentration ratios per pathogen of high and intermediate net household income (NHI) level vs. low NHI with corresponding 95%
C.I. N = 2,172.
When combining all age groups, higher educational level was
significantly associated with higher IgG against measles (GMC
ratio 1.34, 95% CI 1.18–1.53, p < 0.0001) and rubella (GMC
ratio 1.13, 95% CI 1.02–1.25, p = 0.02) compared to lower
educational level, (Figure 1). High educational level was not
significantly associated with IgG levels against mumps, varicella,
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and HiB. In contrast, high educational level was significantly
associated with lower IgG levels against MenC (GMC ratio
0.54, 95% CI 0.44–0.68, p < 0.0001), and pneumococcus
(GMC ratio 0.78, 95% CI 0.70–0.88, p < 0.0001), compared
to lower educational level. Serotype-specific pneumococcal
GMC ratios for high educational level vs. low educational
level for all ages combined ranged between 0.65 (95% CI
0.53–0.79, p < 0.0001) for serotype 6A and 1.02 (95% CI
0.86–1.20, p = 0.841) for serotype 3. Also for CMV higher
educational level was significantly associated with lower IgG
levels compared to lower educational level (GMC ratio 0.23,
95% CI 0.18–0.31, p < 0.0001). GMC IgGs against all pathogens
were calculated per age group and educational level, and are
included in Supplementary Figure 1. All associations were fairly
similar for the different age groups, although for measles,
pneumococcus, and MenC the associations were not significant
in all age groups (Supplementary Figure 3). Interaction with age
categories showed significant results for measles (p = 0.045),
rubella (p = 0.007), and HiB (p = 0.006), indicating different
strengths of the association across the age groups for these
pathogens.
Using NHI as SES indicator for all ages combined revealed
that higher NHI was borderline significantly associated with
higher IgG against measles (GMC ratio 1.12, 95% CI 0.99–
1.26, p = 0.071) (Figure 2). High NHI was not significantly
associated with IgG levels against mumps, rubella, varicella,
HiB, and pneumococcus. High NHI was significantly associated
with lower IgG levels against MenC (GMC ratio 0.68, 95%
CI 0.49–0.94, p = 0.023), and CMV (GMC ratio 0.32, 95%
CI 0.21–0.49, p < 0.0001) compared to low NHI. Serotype-
specific pneumococcal GMC ratios for high NHI compared
to low NHI for all ages ranged between 0.73 (95% CI 0.59–
0.90, p = 0.004) for serotype 9V and 1.11 (95% CI 0.92–1.35,
p = 0.269) for serotype 3. GMC IgGs against all pathogens were
calculated per age group and NHI category, and are included in
Supplementary Figure 2. The observed associations were fairly
similar for the different age groups (Supplementary Figure 4).
Interactions with age category showed significant results for
rubella (p = 0.009), and HiB (p = 0.008). Moreover, both
in the educational level and NHI analysis a dose response
relationship was observed for almost all pathogens, with high
SES differing more from low SES in IgG GMC compared
to the intermediate SES (p-values for trends are included in
Table 2).
When performing a combined analysis of educational level
and NHI, in which we compared participants who were in the
low category for both educational level and NHI to participants
who were in the high category for educational level and NHI,
we observed similar associations (Figure 3). Adjusting for age
category, sex, and ethnicity did not change the general pattern
in all analyses (data not shown).
Finally, we also investigated the associations between
educational level and IgG levels against the antigens tested in the
P1 study, performed 10 years prior to the P2 study. For all ages
combined, we observed similar associations between educational
levels and IgG concentrations against most pathogens (Figure 4),
although, educational level was not significantly associated
TABLE 2 | P-values for trend across the socioeconomic status categories,
education and net household income are analyzed separately.
Education NHI
Measles <0.0001 0.1061
Mumps 0.6785 0.1768
Rubella 0.0929 0.7071
Varicella 0.0645 0.9963
HiB 0.8728 0.4721
MenC 0.0005 0.0477
Pneu 0.0005 0.1000
CMV <0.0001 <0.0001
with IgG levels against measles, mumps, rubella, varicella, and
HiB. Higher educational level was significantly associated with
lower IgG levels against MenC (GMC ratio 0.60, 95% CI
0.39–0.92, p = 0.024) and pneumococcus (GMC ratio 0.74,
95% CI 0.62–0.89, p = 0.001) compared to lower educational
level.
DISCUSSION
In this study, the association between socioeconomic status and
naturally derived IgG antibody concentrations as a measure for
infectious disease induced immune response across different
pathogens was explored. We investigated both educational level
and income as separate SES indicators, and found for both
criteria that, in general, people with lower SES have higher
antibody levels against pneumococcus, MenC, and CMV, and
lower IgG levels against measles. No association was found
between SES and IgG level against mumps, rubella, varicella, and
HiB. After adjusting for age category, sex, and ethnicity, this
pattern remained evident.
The directions of the association observed in our results are,
mostly, supported by earlier research; The Third National Health
and Nutrition Examination Survey (NHANES III, 1988–1994)
in the United States showed that less years of education were
associated with higher antibody levels against CMV in all age
groups, as was a lower family income (24). Data from another
NHANES study (1999–2004), also indicated that individuals
with “less than or equal to high school” educational level, had
lower odds on being measles seropositive (25). However, such
associations were not found for rubella (26). There are studies
indicating that the incidence of HiB disease is higher among
socially disadvantaged populations (27, 28). However, we were
not able to confirm this in our study through different IgG
levels between SES groups. Furthermore, community acquired
pneumonia (CAP), which can be caused by pneumococcus,
is thought to be associated with lower SES (29), and also
the risk of invasive meningococcal disease (IMD) in children
younger than 15 years of age is inversely related to SES factors
such as parental educational level and crowding (30). Also
Cleary and colleagues found an increased risk of meningococcal
carriage with decreasing SES (31). This suggests that lower
antibody levels against these bacteria may indicate less carriage
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FIGURE 3 | Crude geometric mean concentration ratios per pathogen of socioeconomic status (SES) combined. High and intermediate SES compared to low SES
with corresponding 95% C.I. N = 1,256.
of these bacteria and thereby less risk of developing CAP or
IMD.
Interestingly, the association between SES and antibody levels
was clearly different for the various pathogens. Differences
in the nature of the pathogen or differences in carriage
and exposure might be involved in the different outcomes.
Pneumococci, meningococci, and HiB are characterized by
(widespread) carriage among children and adolescents, while
CMV is increasingly present with increasing age (4, 32). Measles,
mumps, rubella and varicella are viruses inducing typical
children’s diseases after which the pathogen is cleared, except for
varicella zoster virus, which remains latently present. In addition,
there is less circulation of these pathogens among the adult
population, as the antibodies provide protection for a long time
(33–36).
Therefore, higher antibody responses to infections such as
pneumococcus and MenC (32), might reflect higher exposure
to these pathogens in low SES individuals. Moreover, pathogen
carriage and exposure might be related to SES factors as well;
for example, air pollution, crowding, or knowledge about (hand)
hygiene might be involved in the frequency and intensity of
carriage and exposure, which can in turn be reflected in IgG
levels against such pathogens. The absence of an association
for HiB might be explained by a lower carriage rate compared
to pneumococcus and MenC, and less disease. This results
in less circulation and fewer differences in exposure and IgG
levels. On the other hand, IgG levels against typical children’s
diseases (i.e., measles, mumps, rubella, and varicella) are more
likely to reflect the primary response evoked by exposure
during childhood, as there is little exposure later in life. As
there are no differences in seroprevalence between the SES
groups for the viruses (all about 99%), primary response
seems important here. On the other hand, for CMV we see
a steep increase of seroprevalence with decreasing SES, which
is indicative for more exposure to the pathogen, perhaps as
a result of difference in hygienic measures or contact with
children. However, more research is needed to study these
hypotheses.
Several elements of this study support the robustness of our
findings. First, the SES indicators that were used (i.e., educational
level and NHI) showed a similar effect on the antibody levels,
although the differences between SES categories were less
outspoken when using NHI (which could have been caused by
smaller numbers). Educational level might better reflect SES
in early life and provides the foundation and knowledge for
healthy behavior, while NHI is a better representative of recent
socioeconomic status and the amount of money people can invest
in their health through nutrition or housing later in life (37).
Including both indicators in the study separately provided us
with a more reliable result as the general pattern was quite
consistent across the indicators. Importantly, a similar pattern
was observed in the P1 study using only educational level as
SES indicator, which validated our results in another study
population. In addition, the results remained evident across age
groups in both P1 and P2. Finally, a dose-response effect was
observed for both the income and educational level, with (for
most of the analyses) the high SES being more different from the
low SES than the intermediate SES.
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FIGURE 4 | Validation in Pienter 1. Crude geometric mean concentration ratios per pathogen of high and intermediate educational level vs. low educational level with
corresponding 95% C.I. N (measles, mumps, rubella) = 3,575, N (varicella) = 629, N (HiB) = 3,571, N (pneumo) = 723, N (MenC) = 749.
The methodological decision to include only participants with
complete data in the analyses was based on the missing NHI data.
As NHI is most likely to be missing not at random (MNAR),
i.e., not depending on measured covariables but on the value
of the variable itself, statistical solutions such as imputation
are not reducing the bias (38). We decided to include only
participants with all determinants available, realizing that we
might be missing a specific set of people in the NHI analysis who
did not want to provide the height of their income, which we
assume is most likely to be rather low or very high. However, the
fact that the same results were found when educational level or
NHI was used as SES indicator is reassuring that the potential
bias induced by the missing NHI data on the association is
minimal.
Some studies use more SES categories or other SES variables
such as poverty level or occupation (16). In the current study,
we only included educational level and NHI as SES indicators,
as no other SES information was available. The categories were
based on the P2 studies (12), however, sometimes a fourth
(education) category is included in health research. We decided
not to do so, as the expected differences between categories were
minor. Moreover, we analyzed the SES indicators separately and
combined, as educational level and NHI are not interchangeable
(16) and found similar results.
Our study included a large sample size from a national
database, which enabled us to assess antibody levels in three
SES categories. Limitations that should be considered include the
cross-sectional design of the serosurvey, which restricted us in
studying causal mechanisms. In addition, data on smoking and
drinking habits were not available in P2, which can be considered
a drawback. This information could have been relevant to
consider, as these are specific lifestyle-related risk factors for
invasive pneumococcal disease (IPD) and IMD (39, 40), and as
it could perhaps have explained the effect of educational level
we found. This also holds for other exposure related variables
that might have explained the observed associations, which we
did not have in the questionnaire or only for a limited number
of people. Although we excluded individuals with documented
or self-reported vaccination against measles and rubella, there
might still be some individuals (in particular in the younger
age classes) that were vaccinated, which could have affected the
measured IgG levels. Finally, an important difficulty embedded
in this study is what should and what should not be taken into
account when studying SES. Socioeconomic status is an abstract
phenomenon and educational level or income is only a proxy to
study this construct (16). SES itself is probably not the causal
factor, but other factors that are represented by or related to
SES might cause differences in IgG responses after infection
(37).
In conclusion, we showed that socioeconomic status is
associated with naturally derived antibody levels and that this
association is pathogen-dependent. The results suggest that
differences in serological response upon infection or differences
in exposure might be involved in the variation in IgG levels
between SES groups. More research is needed to thoroughly
establish this association and the mechanisms through which
differences in antibody levels are induced, to investigate this
association in vaccinated individuals, and to assess whether an
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association can also be established between SES and reported
illness.
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